0.00Open0.00Pre Close0 Volume0 Open Interest105.00Strike Price0.00Turnover451.07%IV-112.55%PremiumDec 13, 2024Expiry Date55.60Intrinsic Value100Multiplier2DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9818Delta0.0028Gamma0.89Leverage Ratio-0.0831Theta-0.0037Rho-0.87Eff Leverage0.0016Vega
Viking Therapeutics Stock Discussion
loading...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
🚀🚀🚀🚀 now all engines firing
No comment yet